Original Research
Published on 10 Dec 2019
An Immune-Related Signature Predicts Survival in Patients With Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01314
- 16,239 views
- 160 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,971 articles
articles
Mini Review
Published on 06 Dec 2019
The Immune Microenvironment in Mesothelioma: Mechanisms of Resistance to Immunotherapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01366
- 15,576 views
- 66 citations
Original Research
Published on 03 Dec 2019
A Diagnostic Panel of DNA Methylation Biomarkers for Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01281
- 8,656 views
- 45 citations
Original Research
Published on 03 Dec 2019
Surgery as a Potential Treatment Option for Patients With Stage III Small-Cell Lung Cancer: A Propensity Score Matching Analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01339
- 3,813 views
- 15 citations
Review
Published on 29 Nov 2019
Epigenetic Regulation of miRNA Expression in Malignant Mesothelioma: miRNAs as Biomarkers of Early Diagnosis and Therapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01293
- 8,757 views
- 50 citations
Opinion
Published on 27 Nov 2019
Mesothelioma Driver Genes, Ferroptosis, and Therapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01318
- 5,901 views
- 8 citations
Case Report
Published on 27 Nov 2019
Genomic Profiling Reveals Synchronous Bilateral Lung Adenocarcinomas With Distinct Driver Alterations of EML4-ALK or TPM3-ROS1 Fusion: A Case Report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01319
- 4,050 views
- 7 citations
Clinical Trial
Published on 26 Nov 2019
Safety and Efficacy Results of a Phase I, Open-Label Study of Concurrent and Delayed Nivolumab in Combination With nab-Paclitaxel and Carboplatin in Advanced Non-small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01256
- 5,322 views
- 12 citations
Original Research
Published on 05 Nov 2019
IL-22 Confers EGFR-TKI Resistance in NSCLC via the AKT and ERK Signaling Pathways
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01167
- 6,941 views
- 21 citations
Original Research
Published on 05 Nov 2019
Prognostic Impact of Metabolism Reprogramming Markers Acetyl-CoA Synthetase 2 Phosphorylation and Ketohexokinase-A Expression in Non-Small-Cell Lung Carcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01123
- 7,812 views
- 30 citations
Original Research
Published on 29 Oct 2019
Detection of Circulating Tumor Cell Molecular Subtype in Pulmonary Vein Predicting Prognosis of Stage I–III Non-small Cell Lung Cancer Patients
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01139
- 7,821 views
- 34 citations
Original Research
Published on 22 Oct 2019
Real World Experience of Crizotinib in 104 Patients With ALK Rearrangement Non-small-cell Lung Cancer in a Single Chinese Cancer Center
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01116
- 6,746 views
- 22 citations
Original Research
Published on 15 Oct 2019
Integrated Network Analysis Reveals FOXM1 and MYBL2 as Key Regulators of Cell Proliferation in Non-small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01011
- 10,066 views
- 54 citations
Original Research
Published on 15 Oct 2019
Clinicopathologic Significance and Immunogenomic Analysis of Programmed Death-Ligand 1 (PD-L1) and Programmed Death 1 (PD-1) Expression in Thymic Epithelial Tumors
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01055
- 4,992 views
- 29 citations
Review
Published on 11 Oct 2019
EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01044
- 17,464 views
- 191 citations
Original Research
Published on 11 Oct 2019
Globular C1q Receptor (gC1qR/p32/HABP1) Is Overexpressed in Malignant Pleural Mesothelioma and Is Associated With Increased Survival in Surgical Patients Treated With Chemotherapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.01042
- 4,704 views
- 9 citations
Original Research
Published on 01 Oct 2019
Combining Plasma miRNAs and Computed Tomography Features to Differentiate the Nature of Pulmonary Nodules
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00975
- 4,329 views
- 20 citations
Original Research
Published on 25 Sep 2019
Double-Stranded DNA in Exosomes of Malignant Pleural Effusions as a Novel DNA Source for EGFR Mutation Detection in Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00931
- 5,992 views
- 44 citations
Original Research
Published on 23 Sep 2019
The Impact of Clinical Factors, ALK Fusion Variants, and BIM Polymorphism on Crizotinib-Treated Advanced EML4–ALK Rearranged Non-small Cell Lung Cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00880
- 5,648 views
- 12 citations
Case Report
Published on 06 Sep 2019
Dramatic Response of Leptomeningeal Carcinomatosis to Nivolumab in PD-L1 Highly Expressive Non-small Cell Lung Cancer: A Case Report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00819
- 9,736 views
- 15 citations
Case Report
Published on 20 Aug 2019
Isolated Rare Urethral Metastasis From Primary Lung Adenocarcinoma: Case Report and Literature Review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00784
- 4,171 views
- 4 citations
Original Research
Published on 14 Aug 2019
A Proposal to Reflect Survival Difference and Modify the Staging System for Lung Adenocarcinoma and Squamous Cell Carcinoma: Based on the Machine Learning
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00771
- 5,944 views
- 16 citations
Systematic Review
Published on 12 Aug 2019
Health-Related Quality of Life in Advanced Non-small Cell Lung Cancer: A Methodological Appraisal Based on a Systematic Literature Review
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00715
- 9,305 views
- 15 citations
Original Research
Published on 06 Aug 2019
Comprehensive Profiling of Gene Copy Number Alterations Predicts Patient Prognosis in Resected Stages I–III Lung Adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2019.00556
- 12,605 views
- 32 citations